Development of new therapies for metastatic pancreatic cancer: are they better than FOLFIRINOX?
ESMO Open
.
2019 Jul 8;4(3):e000537.
doi: 10.1136/esmoopen-2019-000537.
eCollection 2019.
Authors
Gustavo Dos Santos Fernandes
1
,
Allan Pereira
1
Affiliation
1
Division of Medical Oncology, Hospital Sirio-Libanes, Brasília, Brazil.
PMID:
31354965
PMCID:
PMC6615872
DOI:
10.1136/esmoopen-2019-000537
No abstract available
Keywords:
chemotherapy; clinical trials; metastatic disease; pancreatic cancer.